People
This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No 596/2014.
Pharma and biotech companies from across the globe expand their leadership teams and boards.
Karus Therapeutics Ltd, a clinical-stage biopharmaceutical company developing precision medicines for cancer, announced the appointment of Dr Hilary McElwaine-Johnn, MD as Chief Medical Officer with immediate effect.
Great Place to Work is an organization whose goal it is to assure that all people in the U.S. have a great place to work by 2030. One category for certified companies is Biotechnology & Pharmaceuticals, which listed 36 companies. BioSpace organized these 36 companies into its BioSpace Hotbed Regions. Take a look.
Daniel O’Day took over the reins of Gilead Sciences in March and has been building his team of lieutenants.
Arie Belldegrun, founder and former chair, president and chief executive officer of Kite Pharma, has teamed up with real estate developer Tishman Speyer to launch a biotech-focused real estate company, Breakthrough Properties.
Susan Hickman, Ph.D., has been selected to lead the Indiana University Center for Aging Research at the Regenstrief Institute.
Four years ago, Takeda Pharmaceutical Company and The Center for iPS Cell Research and Application (CiRA) at Kyoto University established a 10-year joint research program. Today, the organizations made an announcement.
In November 2018, Chinese researcher He Jiankui announced he had used CRISPR gene editing to modify the CCR5 genes in the embryos of seven Chinese couples. This was met by widespread condemnation, investigations and a call for a global moratorium against that type of research.
Board appointment will help guide target identification and drug discovery
PRESS RELEASES